Navigation Links
TiMAX Pe.R.I. Small Fragment Upper Extremity Plate

ProductsTiMAX Pe.R.I. Small Fragment Upper Extremity Plate
Company DePuy Orthopaedics, Inc.
Item TiMAX Pe.R.I. Small Fragment Upper Extremity Plate
Features 
  • Unique Anatomical Design
  • Pre-contoured
  • Slot Geometry
  • Screw Hole Placement
  • Greater Strength
  • Less Rigidity
  • Superior Biocompatibility
  • Innovative Implant Designs
  • Enhanced Imaging Compatibility
  • Ultra-Low Profile
    • Description The advanced performance benefits of TiMAX material have been applied to the ACE Pe.R.I. (Periarticular Reduction Implants) Upper Extremity Plates. Greater strength, less rigidity combine to provide a complete set of periarticular plates for the upper extremity.
    Info DePuy Orthopaedics, Inc.
    Customer Service: (800) 366-8143
    Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

    Related medicine products :

    1. TiMAX 3.5/4.0 mm Cannulated Screw System
    2. TiMAX 4.5/5.0 mm Cannulated Screw System
    3. TiMAX Pe.R.I. Small Fragment Lower Extremity Plate
    4. Jameson Muscle Hook - Small
    5. Symblepharon Ring - Small
    6. Lambert Chalazion Forceps - Small
    7. Snellen Entropion Forceps - Small - Right
    8. Fukasaku Small Pupil Irrigating Nucleus Chopper
    9. Cervical Retractor Handle - Small
    10. Cougar Small Footprint
    11. Small Teardrop Dissector
    ...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
    ...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
    ...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
    ...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
    Medicine Products:
    (Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
    (Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
    (Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
    (Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
    Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
    ...epressants increase the risk of a gastrointestinal...reuptake inhibitors (SSRIs) are a group of antidep...e preferred over older drugs because they are rela...at Ottawa Hospital in Canada have just shown, they...
    ... that they "enjoy" their habit and don't fear the ...king involves powerful physiological and psycholog...ithout help only a minority succeed. Even smoking ...e helpful to many, have been unable to keep the ma...
    ...twice as likely to have a better quality of life a...uggests. Researchers in a Swiss study looked at pa... chronic angina. Doctors either gave them medicat...ty - a treatment where a fine tube with a small in...
    ...Centre and the Pentagon could affect the mental he... the dust settles over New York and Washington, ps...e full psychological impact of the disaster. Keepi...al keeps anxiety and grief at bay. And the sheer s...
    Other Medicine News:
    (Date:9/5/2008)...The Study Demonstrates microRNAs Extracted From a ...ffective Clinical Biomarkers for a Wide Range of ... Proprietary Technology, Rosetta Genomics is Curre...o Detect Colon Cancer, REHOVOT, Israel and JERSEY...ll/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a lea...
    (Date:9/4/2008)...nother Roche first in TaqMan(R) real-time PCR test... lab, PLEASANTON, Calif., Sept. 4 /PRNewswir...s approved the Roche COBAS(R) TaqMan(R) HBV Test,... DNA approved in the U.S.,The test uses Roche,s re...epatitis B virus DNA in a patient,s blood. Doctors...
    (Date:9/4/2008)...ivotal Study Seeks to Enroll 750 Women at More Tha...4 /- QuatRx Pharmaceuticals, a,privat...lopment and,commercialization of compounds to trea...s, today announced that it has initiated a second,...ablets), the company,s,estrogen-free oral therapy ...
    (Date:9/4/2008)... Optimizing Patient Identification for Ta... of Personalized Treatment HUNTINGTON BEACH, Ca...ire/ -- Agendia, a world leader in molecular cance...tPrint(R), a new diagnostic test that,allows physi...ion levels of,the estrogen receptor (ER), progeste...
    Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 1DiObex and Camurus Sign License Agreement for the Development of DIO 901 in FluidCrystal 28R 29 Extended Release Technology 4031 2Jazz Pharmaceuticals Inc Announces Expansion of Senior Debt 4030 1Jazz Pharmaceuticals Inc Announces Expansion of Senior Debt 4030 2Misys and Allscripts Create a Leader in Healthcare Software 4027 1Reducing HD risk naturally post menopause 14530 1Reducing HD risk naturally post menopause 14530 2